Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG:: an alternative to the antivenom crisis in Africa

被引:90
作者
Gutiérrez, JM
Rojas, E
Quesada, L
León, G
Núñez, J
Laing, GD
Sasa, M
Renjifo, JM
Nasidi, A
Warrell, DA
Theakston, RDG
Rojas, G
机构
[1] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica
[2] Univ Liverpool, Liverpool Sch Trop Med, Alister Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England
[3] Inst Alexander von Humboldt, Bogota, Colombia
[4] Fed Minist Hlth, Abuja, Nigeria
[5] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 2JD, England
关键词
snake venom; antivenom; whole IgG; caprylic acid; neutralization; Africa;
D O I
10.1016/j.trstmh.2004.09.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa. The antivenom is a whole IgG preparation, obtained by caprylic acid precipitation of non-IgG plasma proteins. The antivenom effectively neutralizes the most important toxic activities of the three venoms used in the immunization in standard assays involving preincubation of venom and antivenom before testing. This antivenom compares favourably with other antivenoms designed for use in Africa with respect to neutralization of the toxins present in the venom of E. ocellatus. Caprylic acid fractionation of horse hyperimmune plasma is a simple, convenient and cheap protocol for the manufacture of high quality whole IgG antivenoms. It constitutes a potentially valuable technology for the alleviation of the critical shortage of antivenom in Africa. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:468 / 475
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 1976, ACTA TROP
[2]  
Arroyo O., 1999, ACTA MED COSTARRIC, V41, P23
[3]  
Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515
[4]  
Chippaux JP, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P457
[5]   The development and use of immunotherapy in Africa [J].
Chippaux, JP .
TOXICON, 1998, 36 (11) :1503-1506
[6]   Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol [J].
Chotwiwatthanakun, C ;
Pratanaphon, R ;
Akesowan, S ;
Sriprapat, S ;
Ratanabanangkoon, K .
TOXICON, 2001, 39 (10) :1487-1494
[7]   Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation [J].
García, M ;
Monge, M ;
León, G ;
Lizano, S ;
Segura, E ;
Solano, G ;
Rojas, G ;
Gutiérrez, JM .
BIOLOGICALS, 2002, 30 (02) :143-151
[8]   COMPARATIVE-STUDY ON COAGULANT, DEFIBRINATING, FIBRINOLYTIC AND FIBRINOGENOLYTIC ACTIVITIES OF COSTA-RICAN CROTALINE SNAKE-VENOMS AND THEIR NEUTRALIZATION BY A POLYVALENT ANTIVENOM [J].
GENE, JA ;
ROY, A ;
ROJAS, G ;
GUTIERREZ, JM ;
CERDAS, L .
TOXICON, 1989, 27 (08) :841-848
[9]   MYONECROSIS, HEMORRHAGE AND EDEMA INDUCED BY BOTHROPS-ASPER VENOM IN WHITE MICE [J].
GUTIERREZ, JM ;
ARROYO, O ;
BOLANOS, R .
TOXICON, 1980, 18 (5-6) :603-610
[10]   STANDARDIZATION OF ASSAYS FOR TESTING THE NEUTRALIZING ABILITY OF ANTIVENOMS [J].
GUTIERREZ, JM ;
ROJAS, G ;
LOMONTE, B ;
GENE, JA ;
CHAVES, F ;
ALVARADO, J ;
ROJAS, E .
TOXICON, 1990, 28 (10) :1127-1129